Rare diseases
Investigational molecules
Locations
Back to France16 clinical trials in Gonesse, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis
FranceA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
FranceStudy on Stopping Dimethyl Fumarate and Drug Combination in Patients Aged 55+ with Inactive Relapsing-Remitting Multiple Sclerosis
FranceStudy on Colchicine and Ticagrelor for Preventing Ischemic Stroke in Patients with Atherosclerosis
FranceStudy on Piperacillin-Tazobactam and Temocillin for Treating Severe Infections in ICU Patients with ESBL-Producing Gram-Negative Bacteria
FranceStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
FranceStudy on the Effects of Annual vs. Semi-Annual Ocrelizumab Infusions in Patients with Active Multiple Sclerosis After 2 Years of Initial Treatment
FranceEarly Use of Dexamethasone versus Sodium Chloride Placebo in Patients with Severe Influenza-Induced Acute Hypoxemic Respiratory Failure (Phase III Randomized Trial)
FranceEffectiveness of Tenecteplase in Acute Ischemic Stroke Patients Treated 4.5–24 Hours After Onset Before Transfer for Thrombectomy
FranceComparing tenecteplase and mechanical clot removal versus mechanical clot removal alone for adults with a large ischemic stroke
FranceStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
FranceStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on relapsing multiple sclerosis (RMS) and various treatment approaches. Studies evaluate new therapeutic agents including remibrutinib, ofatumumab, and tolebrutinib for disease management.
Particular emphasis on comparing treatment efficacy and exploring medication administration frequencies.
Research targeting critical care conditions, including septic shock and severe infections. Investigations focus on delirium prevention and treatment alternatives for antibiotic-resistant infections.
Studies aim to improve patient outcomes in intensive care settings through innovative therapeutic strategies.
Clinical trials examining treatments for major vascular events, including stroke and cardiac conditions. Studies evaluate long-term efficacy of medications for preventing recurrent cardiovascular events.
Focus on innovative approaches to reduce cardiovascular complications and improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
